Navigation Links
University of Michigan announces Eric J. Topol Professorship in Cardiovascular Medicine
Date:10/26/2011

SAN DIEGO The University of Michigan Medical School today announced the establishment of the Eric J. Topol Professorship in Cardiovascular Medicine. A world-renowned cardiologist, Dr. Topol is currently chief academic officer at Scripps Health and a senior cardiologist practitioner at Scripps Clinic.

Dr. Topol was a faculty member at the University of Michigan from 1985-1991, a time of rapid advancement in the treatment of acute myocardial infarction. During his time with the university, he served as professor of internal medicine, and later director of the cardiac catheterization labs and the interventional cardiology program in the university's department of internal medicine.

Approved by the University of Michigan's Board of Regents, the creation of this new professorship represents a relatively rare event at the school. It was initiated to honor Dr. Topol's many clinical and research contributions to the subspecialty of interventional cardiology, both to the University of Michigan and the medical field at large. This professorship will support the academic endeavors of a senior University of Michigan faculty member with expertise in cardiovascular medicine.

The inaugural recipient of the professorship is Dr. Stanley Chetcuti, director of the cardiac catheterization labs at the University of Michigan Cardiovascular Center. Dr. Chetcuti trained under Dr. Topol at the Cleveland Clinic, where Dr, Topol chaired the department of cardiovascular medicine for 15 years and raised its status to rank No. 1 by U.S. News & World Report for 11 straight years.

Dr. Topol was instrumental in defining the role of coronary thrombolysis as a lifesaving treatment for acute myocardial infarction. He also has made seminal contributions in understanding the role of platelets, percutaneous coronary interventions and genetics in acute coronary syndromes. He has been recognized by the Institute of Scientific Information (ISI) to be in the top 10-cited biomedical researchers in medicine during the past decade.

He was elected to the membership of the Institute of Medicine, National Academy of Sciences in 2004. Dr. Topol's work in the genomics of heart attack has led to discovery of key genes recognized by the American Heart Association twice as top 10 research advances, as well as recognition by Time Magazine as a top 10 medical breakthrough in 2010.

Dr. Topol also currently serves as director of the National Institutes of Health-funded Scripps Translational Science Institute, which he founded in 2007. In addition, he is a founder and vice chairman of the West Wireless Health Institute.


'/>"/>
Contact: Steve Carpowich
carpowich.stephen@scrippshealth.org
Scripps Health
Source:Eurekalert

Related medicine news :

1. University of Virginia Health System Medical Laboratories Selects Sunquest's Specimen Collection Solution
2. Akron Institute of Herzing University Launches Its First Bachelors Degree Programs to Prepare Students for Even Greater Success in Business, Health Care and IT
3. Most pandemic plans in Ontario hospitals have not been tested: Queens University study
4. San Diego State University and BIOCOM Institute Receive $4.95 Million Grant: The BRIDGE Project, Linking Education to Employment in San Diegos Life Sciences Industry
5. Smithsonian Institution, Arizona State University announce education and research partnership
6. Untreated poor vision in elderly linked to dementia, University of Michigan study shows
7. Giarmarco, Mullins & Horton, P.C. President Joseph F. Page to Speak at University of Michigan
8. Arizona State Universitys Decision Theater offers balance to an off-kilter world
9. Forest City Announces Joint Venture with Health Care REIT for University Park Life Science Properties
10. Herzing University Online Launches Master and Bachelor of Science Degrees in Nursing
11. Nurtur Acquires ActivHealth and Wellness by Choice; Gains Exclusive Partnership with Duke University Center for Living
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... WHO: , Dr. Paul Thomas; Dr. Brian Hooker; Dr. Judy Mikovits; Dr. ... will speak to the press on behalf of over 200 doctors, scientists, and scientific ... commission. , WHERE: , Zenger Room, National Press Club, 529 14th Street NW, ...
(Date:3/28/2017)... ... 2017 , ... Award-winning medical group Allied Anesthesia today announced ... chair for Orange County health care system CalOptima Friday. CalOptima announced its election ... Mark Refowitz’s term, which runs through June 30 of this year, until another ...
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER TOLEDO ... found in power plant water and steam. , Chlorides and sulfates cause pitting ... leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at low ppb ...
(Date:3/28/2017)... ... March 28, 2017 , ... A ... achieve the “perfect smile.” The National Association of Dental Laboratories (NADL) is informing ... should be aware of when utilizing dental laboratories and technicians that create these ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Lice ... Atlantic City March 13-16, was a busy spot this year. Liz Solovay and ... strategies for preventing outbreaks among camp communities during the upcoming 2017 camping season. ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... and TORONTO , March 28, 2017 ... leading full service medical device development firm, announced today ... Toronto -based medical device industrial design ... serve medtech companies throughout North America ... experienced medical device talent spanning the design, engineering, regulatory, ...
(Date:3/28/2017)... United Kingdom and  BOSTON , March 28, ... Linguamatics today announced a partnership with ... The agreement allows pharmaceutical companies to extract key ... I2E text mining technology. The ... of the top 20 global pharmaceutical companies. The ...
(Date:3/28/2017)... , March 28, 2017 Emosis SAS, ... new business entity, Emosis Ltd, headquartered in Tel Aviv ... novel assays complementing the mother company existing technology platform and test ... sales development of Emosis kits. ... This strategic move starts building Emosis international footprint. Emosis ...
Breaking Medicine Technology: